Scholarlink

<p>The escalating antimicrobial resistance crisis has propelled bacterial infections to the forefront of global health challenges. Therefore, it is particularly important to develop new antimicrobial drugs, such as antimicrobial peptides. The present study aims to characterize a novel attacin-like antimicrobial peptide and explore its antibacterial mechanism against <i>Staphylococcus aureus</i> (<i>S. aureus</i>). In this study, a novel attacin, referred to as CpAtt, was identified from <i>Conogethes punctiferalis</i> (<i>C. punctiferalis</i>). CpAtt was characterized by bioinformatics analysis and in vitro experiments. The results suggested that the novel attacin CpAtt owned an open reading frame (ORF) of 609&#xa0;bp in length, encoding 202 amino acids. Sequence alignment and homology modeling analysis revealed that CpAtt formed a β-barrel structure with electrostatic heterogeneity, suggesting a potential pore-forming mechanism through transmembrane disruption. The recombinant protein CpAtt exhibits preferential efficacy against Gram-positive bacteria. SEM observation proved that <i>S. aureus</i> treated with CpAtt exhibits severe deformities. Molecular docking analysis predicted that CpAtt might bind to Lipid II and lipoteichoic acid. However, CpAtt was determined to have concentration-dependent hemolytic activity. This study identified a novel attacin, CpAtt, and successfully expressed CpAtt in <i>E. coli</i>, exhibiting effective antibacterial activity on Gram-positive bacteria, which establishes a robust foundation for the precise elucidation of CpAtt's antibacterial mechanisms and optimization of derived peptide design.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification and antibacterial activity of a novel antimicrobial peptide attacin from Conogethes punctiferalis

  • 期刊论文

  • 发表日期：

    2025年8月12日

查看全文
  • Yuhang Wang,
  • Lingling Zhou,
  • Qian Feng,
  • Shuai Wang,
  • Xiangfeng Meng,
  • Kaiqi Lian,
  • Zengjun Ma

摘要

The escalating antimicrobial resistance crisis has propelled bacterial infections to the forefront of global health challenges. Therefore, it is particularly important to develop new antimicrobial drugs, such as antimicrobial peptides. The present study aims to characterize a novel attacin-like antimicrobial peptide and explore its antibacterial mechanism against Staphylococcus aureus (S. aureus). In this study, a novel attacin, referred to as CpAtt, was identified from Conogethes punctiferalis (C. punctiferalis). CpAtt was characterized by bioinformatics analysis and in vitro experiments. The results suggested that the novel attacin CpAtt owned an open reading frame (ORF) of 609 bp in length, encoding 202 amino acids. Sequence alignment and homology modeling analysis revealed that CpAtt formed a β-barrel structure with electrostatic heterogeneity, suggesting a potential pore-forming mechanism through transmembrane disruption. The recombinant protein CpAtt exhibits preferential efficacy against Gram-positive bacteria. SEM observation proved that S. aureus treated with CpAtt exhibits severe deformities. Molecular docking analysis predicted that CpAtt might bind to Lipid II and lipoteichoic acid. However, CpAtt was determined to have concentration-dependent hemolytic activity. This study identified a novel attacin, CpAtt, and successfully expressed CpAtt in E. coli, exhibiting effective antibacterial activity on Gram-positive bacteria, which establishes a robust foundation for the precise elucidation of CpAtt's antibacterial mechanisms and optimization of derived peptide design.